Recent development in targeting PI3K-Akt-mTOR signaling for anticancer therapeutic strategies.

Abstract excerpt

Cancer is a diverse class of diseases which differ widely in their cause and biology. The aberrant behavior of cancer reflects up regulation of certain oncogenic signaling pathways that promote proliferation, inhibit apoptosis, and enable the cancer to spread and evoke angiogenesis. Phosphoinositide-3-kinase(PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway controls various biological processes that are...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Intercellular Signaling Peptides and Proteins
• Share to Molecular Targeted Therapy